11/15
Cancer Research
A new cancer drug, thanks to a new approach
A new cancer drug, thanks to a new approach
Researchers in the Abramson Cancer Center helped bring new hope to patients with multiple myeloma with a drug that targets the command center of a cancer cell.
Hormone therapy for prostate cancer may raise risk of Alzheimer’s, dementia
Hormone therapy for prostate cancer may raise risk of Alzheimer’s, dementia
A Penn study of more than 150,000 men with prostate cancer shows androgen deprivation therapy was associated with a higher likelihood of developing dementia when compared to patients who were not exposed to the treatment.
Shorter courses of proton therapy can be just as effective on prostate cancer
Shorter courses of proton therapy can be just as effective on prostate cancer
Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments, and is safe for patients.
One simple change can reduce frequent cancer imaging by half
One simple change can reduce frequent cancer imaging by half
A “nudge” is helping shorten treatment time for patients with advanced cancer, with less frequent palliative radiation therapy sessions.
Elderly patients with metastatic renal cell carcinoma benefit from targeted therapies
Elderly patients with metastatic renal cell carcinoma benefit from targeted therapies
A Penn study of Medicare patients who are often underrepresented in medical trials finds overall survival benefits from treatment with targeted therapies.
Chemo is a go for treating equine lymphoma
Chemo is a go for treating equine lymphoma
New Bolton Center’s Daniela Luethy’s research on 15 horses with lymphoma concluded that chemotherapy had encouraging results. Her study poses opportunities for further research with more case control.
How to reinvigorate exhausted immune cells to stop cancer
How to reinvigorate exhausted immune cells to stop cancer
A Penn study has identified a protein called TOX that regulates exhausted T-cells, and could be a key to new immunotherapies.
OncoLink: 25 years—and millions of hits—later
OncoLink: 25 years—and millions of hits—later
The online source for cancer information turns 25. Last year alone, the website had 4.5 million visits, with half from other countries, and nurses looking for reliable material to educate patients.
Better prognosticating for dogs with mammary tumors
Better prognosticating for dogs with mammary tumors
For dogs with mammary tumors, a course of treatment can depend on a variety of factors, some of which may seem to contradict one another. A new system developed by Penn Vet’s Karin Sorenmo and colleagues can make determining a prognosis and making treatment decisions an easier task.
Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients
Finding clues to a genetic link to treatment for BRCA1/2 breast cancer patients
New research could shape treatment strategies and clinical trial design for patients with BRCA1 and BRCA2-related breast cancers.
In the News
Forbes
Carl June: 2024 will be seen as a breakthrough year for brain cancer
Carl June of the Perelman School of Medicine shares five insights on using CAR T cell therapy to combat cancer, featuring remarks from Bruce Levine.
FULL STORY →
Philadelphia Inquirer
Penn plans to build a proton center for cancer treatment at Presbyterian Medical Center
Penn Medicine will build its fourth proton beam center for cancer treatment at Penn Presbyterian Medical Center in University City.
FULL STORY →
PhillyVoice
Double mastectomies do not improve breast cancer survival likelihood for most women, study finds
Angela DeMichele of the Perelman School of Medicine says that chemotherapy and hormonal therapies are important for combating breast cancer because they’re designed to kill spreading cells.
FULL STORY →
The New York Times
Breast cancer survival not boosted by double mastectomy, study says
Angela DeMichele of the Perelman School of Medicine comments on a study which found that breast cancer survival is not boosted by a double mastectomy.
FULL STORY →
Today
How did Shannen Doherty die? What to know about ‘90210’ star’s cause of death
According to Penn Medicine, there is no known cure for metastatic breast cancer.
FULL STORY →
Stat
New immunotherapy combination could ‘change the landscape’ of cancer treatment
A study by Andy Minn and postdoc Divij Mathew of the Perelman School of Medicine and colleagues found that a combination checkpoint inhibitor therapy benefited patients with lung cancer.
FULL STORY →